Drug Development
Compound May Hold Promise as Anti-Tumor Agent in Ovarian and Pancreatic Cancer
Published in Women's Health Weekly, August 24th, 2000
The encouraging results specifically deal with irofulven, a drug candidate derived from the acylfulvene compound family, and which is currently being developed by MGI PHARMA, Inc., a pharmaceutical company based in Minneapolis, Minnesota.
Irofulven is particularly effective in shrinking tumors associated with pancreatic and ovarian cancer, especially among those patients who are no longer responding appropriately to such conventional cancer drugs as gemcitabine,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Women Over Age 80 Less Likely to Receive Full Range of Treatments - Gender Issues
Health Research Society Recommendations Implemented by NIH - Ovarian Cancer
Study: Most Cases Detected by Transvaginal Ultrasonography Screening are Curable - Breast Cancer
'Breast Buddy' Program Improves Cancer Care Satisfaction - Cancer Screening
Rates for Asian American and U.S. Pacific Islander Women Well Below U.S. Guidelines - Coeliac Disease
Condition Associated with Recurrent Miscarriage and Fetal Growth Retardation - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
